Similar results on HF have been recently reported with another SGLT2 inhibitor, canagliflozin, in the recently published CANVAS study [15] and also in a large observational study on users of SGLT-2 inhibitors (CVD-REAL) in which the majority of the subjects were treated with dapagliflozin [16]. Here, SLC5A2 is linked to hydrops fetalis.